Menu
Search
Home > Courses > Best of ACTHIV: Real World HIV Liver Disease (HCV) Cases

Best of ACTHIV: Real World HIV Liver Disease (HCV) Cases

Best of ACTHIV: Real World HIV Liver Disease (HCV) Cases
Play
Sorry, this learning module is not available for mobile devices.
ACTHIV
Original Release Date: 9/15/2019
Review Date: 9/15/2019
Presenter
  • Oluwaseun O Falade-Nwulia, MBBS, MPH
    Assistant Professor of Medicine
    Johns Hopkins University School of Medicine
Learning Objectives / Desired Outcomes
At the completion of this educational activity, participants will:
  1. Analyze the implications of timing of antiretroviral (ARV) exposure on birth defect risk.
  2. Describe the results of the Botswana Tsepamo birth surveillance study related to preconception dolutegravir (DTG) use and neural tube defects (NTD) and what they mean for practice in the U.S.
  3. Appraise the importance of prospective reporting of antiretroviral drug exposure in pregnancy to the Antiretroviral Pregnancy Registry.
Presenter Bio
Oluwaseun Falade-Nwulia, MBBS, MPH
Dr. Falade-Nwulia is an Assistant Professor at the Johns Hopkins University School of Medicine. She has focused her clinical pursuits on care of HIV and HCV infected patients and educating clinicians and public health practitioners about STDs, HIV, and hepatitis. She previously served as Medical Director of the Baltimore City Health Department Sexually Transmitted Diseases Clinic based HIV care programs until 2015 and also developed and implemented the Baltimore City Health Department hepatitis C testing, linkage to care and treatment programs, establishing the Baltimore City Health Department as a national leader in health department population hepatitis C control programs.
Continuing Education Credit (The CE accreditation for this course has expired - this section is only for your information)

The enduring material is jointly provided by Beaumont Health, American Academy of CME, Inc., and the American Conference for the Treatment of HIV (ACTHIV).

The 13th Annual American Conference for the Treatment of HIV (ACTHIV) was held April 11-13, 2019 in Miami, FL. The Conference was supported by the Clinical Education Initiative, New York State Department of Health, AIDS Institute. The conference and this web archive were supported by educational grants from Gilead Sciences; Janssen Therapeutics, Division of Janssen Products, LP; Merck & Co., and ViiV HealthCare.

Hardware/Software Requirements To access this activity hardware and software requirements are noted below.

Windows Requirements: • Operating system: Windows XP Service Pack 2 or later • Browser: Internet Explorer 7 or later, Mozilla Firefox 2.5 or later • Internet connection: DSL, cable modem, or other high-speed connection • Flash: Adobe Flash Player 9 or later
Macintosh Requirements: • Operating system: Mac OS X v10.3 or later • Browser: Mozilla Firefox 2.5 or later • Internet connection: DSL, cable modem, or other high-speed connection • Flash: Adobe Flash Player 9 or later

Copyright 2019. American Academy of CME, Inc., Beaumont Health, and American Conference for the Treatment of HIV.

Resources: